Abstract
Simple Summary
More than 50% of atypical meningiomas recur within 5 years. Identification of high-risk tumors might be helpful for pre-operative planning. The aim of our retrospective study was to assess the value of radiomic and semantic magnetic resonance imaging (MRI) characteristics for the prediction of tumor relapse. Our findings suggest that the semantic characteristic of cystic component and the radiomic feature of cluster prominence are associated with tumor recurrence. A combination of semantic and radiomic characteristics is a promising tool for identifying patients with high-risk atypical meningiomas.
Abstract
Up to 60% of atypical meningiomas (World Health Organization (WHO) grade II) reoccur within 5 years after resection. However, no clear radiological criteria exist to identify tumors with higher risk of relapse. In this study, we aimed to assess the association of certain radiomic and semantic features of atypical meningiomas in MRI with tumor recurrence. We identified patients operated on primary atypical meningiomas in our department from 2007 to 2017. An analysis of 13 quantitatively defined radiomic and 11 qualitatively defined semantic criteria was performed based on preoperative MRI scans. Imaging characteristics were assessed along with clinical and survival data. The analysis included 76 patients (59% women, mean age 59 years). Complete tumor resection was achieved in 65 (86%) cases, and tumor relapse occurred in 17 (22%) cases. Mean follow-up time was 41.6 (range 3–168) months. Cystic component was significantly associated with tumor recurrence (odds ratio (OR) 21.7, 95% confidence interval (CI) 3.8–124.5) and shorter progression-free survival (33.2 vs. 80.7 months, p < 0.001), whereas radiomic characteristics had no predictive value in univariate analysis. However, multivariate analysis demonstrated significant predictive value of high cluster prominence (hazard ratio (HR) 5.89 (1.03–33.73) and cystic component (HR 20.21 (2.46–166.02)) for tumor recurrence. The combination of radiomic and semantic features might be an effective tool for identifying patients with high-risk atypical meningiomas. The presence of a cystic component in these tumors is associated with a high risk of tumor recurrence.
Keywords: atypical meningioma, survival, radiomics, prediction
1. Introduction
Atypical meningiomas (World Health Organization (WHO) grade II) comprise an intermediate group of tumors between benign (WHO grade I) and rare malignant (WHO grade III) meningiomas [1]. Following the latest WHO revision of histological criteria, the proportion of atypical meningiomas increased from about 5% to more than 20% [2]. Tumor recurrence is observed in 30–60% of patients within 5 years after surgical resection, and the extent of resection emerges as the most consistent risk factor in retrospective studies [3,4]. Additional risk factors include age, the use of postoperative radiation and tumor location [4,5,6]. Some histological and molecular markers have been described and correlated with a poorer outcome and a shorter progression-free survival (PFS) [7,8]. These advances are leading to a better understanding of the biological behavior of meningiomas. However, there is no ubiquitous availability of molecular and genetic diagnostic procedures. Therefore, there is a strong need for defined risk stratification factors. Unambiguous radiological criteria that could fill that void have not been established yet.
Radiomics, a method that processes imaging data according to various mathematical algorithms, allows for extraction of data that cannot be detected by the human observer. These algorithms are promising for the characterization of tumor type and behavior of some cancers [9,10]. Neuro-oncologists have successfully applied radiomics in the survival assessment of glioblastoma [11]. Recent studies on the use of radiomic analysis for meningiomas suggest that they can be used to estimate WHO grades [12,13,14], with close to 90% accuracy [15]. Radiomics could also be applied for the preoperative differentiation of meningioma subtypes [16]. Furthermore, the combination of both radiomic and visual identification of macroscopic (or semantic) characteristics has allowed for meningioma classifications based on WHO grading [12]. Therefore, we sought to evaluate the usefulness of a combined approach to identify the atypical meningiomas at high risk of recurrence, which could help clinicians optimize pre-operative planning of the tumor removal and further treatment.
2. Results
2.1. Patients
A total of 76 patients (59% women) with atypical meningioma were identified in our database. Table 1 shows the major demographic and tumor characteristics of the patients. The mean age was 58.7 years, range 12–81 years. The majority of tumors were localized on the convexity and in the falx. In 65 (86%) cases, the tumors could be resected completely (Simpson grade 1 or 2). Postoperative radiation was used to treat 22 (29%) patients, and tumor recurrence was observed in 17 (22%) cases. Mean follow-up time was 41.6 months (range 3–168 months). In 43 (57%) cases, each brain invasion, as well as 4–19 mitotic figures, were histologically identified, while in 26 (34%) cases, both criteria overlapped. Immunohistochemical analysis revealed no loss of the trimethylation of histone H3K27 (H3K27me3). We found a mutation in the telomerase reverse transcriptase (TERT) promotor in 3 (4%) cases, and one of these patients presented with a tumor relapse after 31 months.
Table 1.
Characteristic | All Patients | Radiomic Data Available | Semantic Data Available |
---|---|---|---|
N (%) | 76 (100) | 51 (67.1) | 55 (72.4) |
Age (SD) | 58.7 (13.8) | 59.1 (14.1) | 58.8 (13.9) |
Women, % | 59.2 | 64.7 | 65.5 |
Tumor localization, % | |||
Convexity/falx | 59.2 | 58.8 | 61.8 |
Scull base | 39.5 | 39.2 | 36.4 |
Ventricular | 1.3 | 2 | |
Simpson Grade, % | |||
1° | 71.1 | 66.7 | 68.5 |
2° | 14.5 | 15.7 | 14.5 |
3° | 7.9 | 7.8 | 9.1 |
4° | 5.3 | 7.8 | 7.3 |
Postoperative radiation, % | 28.9 | 31.4 | 30.9 |
Tumor relapse, N (%) | 17 (22.4) | 11 (21.6) | 15 (27.3) |
SD—standard deviation.
Preoperative MRI data used for extraction of radiomic features were available from 51 (67%) patients, and semantic features could be described for 55 (72%) patients. No preoperative imaging could be found in the database for 21 (28%) patients. The major characteristics of the patients with radiomic and semantic data were similar to those of the entire patient population (Table 1).
2.2. Semantic and Radiomic Features
Using univariate logistic regression analysis of semantic features, we found that the cystic component (Figure 1) was significantly associated with tumor relapse (odds ratio (OR) 21.7, 95% confidence interval (CI) 3.8–124.5). Univariate analysis of radiomic features showed a predictive trend for cluster prominence (area under the curve (AUC) 0.663, p = 0.10). Therefore, an arbitrary threshold of 91,000 was calculated for cluster prominence based on the Youden’s index; however, it did not reach statistical significance (OR 3.8 (95% CI 0.93–15.5). These two features were included in a multivariate analysis, which found a significant association with tumor recurrence (Table 2). We did not observe a correlation between cystic component and cluster prominence.
Table 2.
Univariate Analysis | Odds Ratio | 95%CI |
---|---|---|
Intra-tumoral heterogeneity | 0.19 | 0.02–1.61 |
Multifocality | 0 | |
Midline shift | 2.75 | 0.75–10.11 |
Sinus invasion | 0.62 | 0.12–3.30 |
Necrosis Hemorrhage | 2.71 | 0.78–9.38 |
Mass effect | 4.67 | 0.54–40.11 |
Cystic component† | 21.74 | 3.79–124.54 |
Bone invasion | 2.12 | 0.64–7.08 |
Hyperostosis | 2.04 | 0.60–6.91 |
Spiculation | 1.18 | 0.31–4.45 |
Edema | 1.18 | 0.31–4.45 |
High cluster prominence * | 3.79 | 0.93–15.47 |
Multivariate Analysis | Hazard Ratio | 95%CI |
Cystic component † | 20.21 | 2.46–166.02 |
High cluster prominence †,* | 5.89 | 1.03–33.73 |
* cluster prominence more than 91,000, † p < 0.05, CI—confidence interval.
We then analyzed the association of progression-free survival with radiomic and semantic features and clinical characteristics. For this purpose, resected tumors were classified as complete (Simpson grade 1 + 2) or incomplete (Simpson grade 3 + 4). Univariate analysis found a significant association between progression-free survival and completeness of resection OR 0.35 (95% CI 0.12–0.99), as well as with the feature cystic component OR 9.77 (95%CI 3.14–30.41) (Table 3). Cystic component was identified in 9 meningiomas and was associated with significantly shorter PFS (mean PFS 33.2 vs. 80.7 months, p < 0.001 (log-rank test), Figure 2). Postoperative radiation was not a statistically significant factor for PFS OR 2.12 (95%CI 0.81–5.53). PFS association with telomerase reverse transcriptase (TERT) promoter mutation and the loss of trimethylation of histone H3K27 (H3K27me3) could not be evaluated due to the low rate of identified TERT promotor mutations and no case of loss H3K27me3. In a multivariate analysis, only cystic component remained significantly associated with PFS (hazard ratio (HR) 22.74 (95%CI 4.29–120.66)) (Table 4).
Table 3.
Univariate Analysis | Odds Ratio | 95%CI |
---|---|---|
Completeness of resection † | 0.35 | 0.12–0.99 |
Tumor localization ‡ | 1.62 | 0.59–4.47 |
Gender | 0.44 | 0.17–1.17 |
Age older than 65 years | 1.36 | 0.50–3.68 |
Postoperative radiation | 2.12 | 0.81–5.53 |
Cystic component † | 9.77 | 3.14–30.41 |
High cluster prominence * | 1.15 | 0.32–4.09 |
Multivariate Analysis | Hazard Ratio | 95%CI |
Completeness of resection | 1.27 | 0.31–5.24 |
Cystic component † | 22.74 | 4.29–120.66 |
High cluster prominence * | 1.35 | 0.34–5.47 |
* cluster prominence more than 91,000, ‡ Falx and convexity vs. Scull base, † p < 0.05.
Table 4.
Radiomic Characteristics | Semantic Characteristics | Clinical Characteristics |
---|---|---|
Mean | Intra-tumoral heterogeneity | Age |
Median | Multifocality | Gender |
Minimum | Midline shift | Tumor localization |
Skewness | Sinus invasion | Completeness of resection |
Spherical Disproportion | Necrosis/Hemorrhage | Postoperative radiation |
Cluster Prominence | Mass effect | Progression-free survival |
Difference Entropy | Cystic component | |
Inverse Difference Normalized | Bone invasion | |
Run Length Non-uniformity | Hyperostosis | |
Short-Run Low Gray-Level Emphasis | Spiculation | |
High-Intensity Large Area Emphasis | Edema | |
Low-Intensity Large Area Emphasis | ||
Low-Intensity Small Area Emphasis | ||
Filters | ||
Wavelet | ||
Laplacian of Gaussian |
3. Discussion
In this study, we evaluated the radiomic and semantic criteria of atypical meningiomas with regard to the prediction of tumor recurrence. We found that tumors presenting with cystic component or high cluster prominence were associated with tumor recurrence. Cystic component was strongly associated with a shortened PFS. Univariate analysis found a significant association of the extent of tumor resection with PFS. Other clinical parameters, including postoperative radiation, did not improve the PFS. Even though the completeness of resection was not consistently significant in multivariate analysis, residual tumor is a well-established risk factor for meningioma recurrence [4,17,18]. Because of conflicting results from retrospective studies, the effect of postoperative radiation remains controversial [4,17,19,20,21,22], while no prospective data is available yet.
Some meningioma characteristics such as the presence of tumor fringes (suggesting invasion of the brain tissue) and intra-tumoral hypodense areas were recognized as signs of atypia or malignancy early on [23]. Coroller et al. [12] found that 8 radiomic and 4 semantic characteristics could be used for prediction of WHO grade, and showed the potential for identifying more aggressive tumors. However, WHO grading does not completely reflect tumor behavior. For example, stratification according to apparent diffusion coefficient (ADC) and Simpson grading outperformed WHO grading for the prediction of tumor recurrence [24], meaning that the integration of available data is needed for patients at high-risk within WHO grades.
Among radiomic characteristics analyzed, high cluster prominence demonstrated a predictive value for tumor recurrence in a multivariate analysis. It is a feature which is sensible to the areas of similar intensity within the tumor. The association of cluster prominence with more aggressive tumors is in accordance with the finding of Coroller et al. [12], as it has shown a classifying value (AUC 0.65) for atypical meningiomas, together with 3 other radiomic features (mean intensity, low-intensity small area emphasis and difference entropy). Even though cluster prominence showed a prognostic value for tumor recurrence in a multivariate analysis, there was no significant association with PFS. The only significant feature associated with PFS in univariate and multivariate analyses was cystic component.
Several studies suggested that cystic component is a predictor for a more aggressive tumor behavior [17,25,26]. A study of 75 patients with 59 benign and 16 atypical or malignant meningiomas, which evaluated 6 imaging features potentially associated with aggressive tumor behavior, found that only intra-tumoral cystic change and extracranial tumor extension were significantly associated with high tumor grade [25]. Another study of patients with atypical meningiomas found that heterogeneous enhancement, cyst formation and peritumoral edema were associated with tumor recurrence [17]. A systematic review of 35 studies demonstrated that cyst formation and tumor heterogeneity were associated with higher WHO grade; however, it was mostly not related to progression [26]. Epigenetic modification on the level of histones, namely the loss of H3K27me3 [27], as well as TERT promoter mutation [8] were associated with increased risk of meningioma recurrence. In our study cohort, all cases showed a retained trimethylation of histone H3K27. Furthermore, only in 4% of cases was a TERT promotor mutation \identified. Consequently, a clinical impact of these molecular markers could not be evaluated.
Other radiological features also appear to show an association with higher tumor grade. Apparent diffusion coefficient (ADC) has been shown to be correlated with WHO grade in a multicenter study [28]. Another group was able to classify patients according to WHO grade using the combination of Fluid-attenuated inversion recovery (FLAIR), T1 contrast-enhanced and ADC sequences [14]. Altogether, these results indicate that newly developed analysis algorithms are promising tools for a more nuanced tumor stratification. Machine learning algorithms that were implemented to predict meningioma grade on preoperative MRIs have been shown to be highly accurate [29].
The results of our study must be interpreted with caution because of its retrospective nature, small patient sample and limited number of radiomic criteria used. However, we think that the combination of radiological data together with known clinical data and established risk factors should be effective for the identification of high-risk patients. If verified, this approach might lead to a machine learning-based software solution for MRI interpretation and be helpful for the selection of the optimal treatment strategy for patients for whom observation and surgery can be considered.
4. Materials and Methods
4.1. Patient Sample and Study Design
We identified patients with meningiomas who underwent surgery in our department from 2007 to 2017 in our database. The inclusion criteria were: histological confirmation of primary (i.e., not manifesting the progression of WHO grade I meningiomas) atypical intracranial meningiomas and at least one postoperative follow-up ≥3 months after surgery. Patients with history of neurofibromatosis and previous brain radiation were excluded from the study. In addition to standard histological work-up for meningioma (Hematoxylin and eosin (HE), Reticulin stain, Ki67-immunohistochemistry), the tumor samples were screened for Telomerase reverse transcriptase (TERT) promoter mutations as well as loss of trimethylation of histone H3K27 (H3K27me3). Radiomic analysis was performed on preoperative MRI scan with contrast-enhanced (CE) T1 sequences. In case of insufficient quality (movement artefacts, distortions, inability to import into the software, etc.), the imaging was not used for extraction of radiomic characteristics. However, it could be used for analyzing semantic characteristics in some cases. Among patients with multiple MRI scans, MR images acquired nearest the date of surgery were selected.
4.2. Radiomic and Semantic Analysis
Tumor volume was extracted from contrast-enhanced T1 sequences by three-dimensional (3D) Slicer software Version 4.8.1 (www.slicer.org) using a manual segmentation [30,31]. Radiomic features were extracted by an in-house Matlab-script (Matlab R2017b, The MathWorks, Inc. (Natick, MA, USA)) based on the tools and methods described by Vallières et al. [32] and Coroller et al. [12]. Because radiomics entails a large number of quantitative imaging features, we reduced redundancy for the comparison of prognostic features. We chose our characteristics according to the study by Coroller et al. [12], to classify meningiomas into WHO grades based on their semantic and radiomic features, as these characteristics have shown the most potential to define the tumor aggressiveness. A total of 13 quantitatively defined radiomic characteristics were used along with wavelet and Laplacian of Gaussian filters (Table 4 and Table S1). Semantic analysis was done by two experienced neurosurgeons independently. In case of disagreement, the certain feature was reviewed and agreed upon. Eleven semantic features in total were defined qualitatively (as a presence or absence of certain characteristics, Table 4 and Table S1).
4.3. H3K27me3 Immunohistochemistry
Immunohistochemistry was performed on 4 µm thick routinely processed formalin-fixed and paraffin-embedded tissue sections. After dewaxing, antigen retrieval using EnVision FLEX Target Retrieval Solution, high pH (Dako #S2368 Glostrup, Denmark), was performed. Afterwards, endogenous peroxidase was blocked by peroxidase blocking solution (DAKO, Glostrup, Denmark) and sections were stained with anti-Tri-Methyl-Histone H3 (Lys27) primary antibody 1:200 (Cell Signaling Technology, Leiden, The Netherlends) using an immunostainer (Dako Autostainer Plus, DAKO, Glostrup, Denmark). Immunoreactivity was visualized by the universal immuno-enzyme polymer method (Nichirei Biosciences, Tokyo, Japan). Finally, sections were developed in diaminobenzidine (Lab Vision Cooperation, Fermont, CA, USA). Omission of the primary antisera in a subset of control slides resulted in no immunostaining at all. Analysis of nuclear H3K27me3 immunostaining was performed by an experienced neuropathologist (CJS).
4.4. Sequencing of Genomic DNA from Formalin-Fixed, Paraffin-Embedded Meningioma Samples
Tumor areas of 76 meningioma paraffin sections were scratched off according to corresponding HE-staining and DNA preparation was performed using a QIAamp DNA FFPE Tissue Kit (Qiagen, Hilden, Germany). Polymerase chain reaction (PCR) reactions were performed in 25 µL reaction mixture using FastStart™ Taq DNA Polymerase-Kit (Merck KGaA, Darmstadt, Germany), with forward (5′-CCG TCC TGC CCC TTC ACC-3′) and reverse (5′-GGG CCG CGG AAA GGA AG-3′) TERT-specific primers. PCR products were directly sequenced using the CEQ Dye terminator cycle sequencing reagents (Beckman Coulter, Brea, CA, USA) with the Beckman CEQ 8800 capillary gel electrophoresis system. Sequence results were analyzed by Chromas, DNA sequencing software (Technelysium Pty Ltd., South Brisbane, Australia).
4.5. Statistics
The data were assessed along with clinical information that included the following characteristics: patient age, gender, completeness of tumor removal and PFS (Figure 3). The effect of postoperative radiation was evaluated. Univariate and multivariate regression analysis as well as receiver operator characteristics (ROC) curve analysis were performed using SPSS software, Version 26.0 (IBM Corporation, Armonk, NY, USA), and used to evaluate the tumor features and clinical data in association with patient outcome.
4.6. Ethical Approval
The ethics committee of Rhineland-Palatinate, Germany, reviewed and approved this study (837.476.17 (11310)). All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
5. Conclusions
The combination of radiomic with semantic features might be a helpful tool for identifying patients with high-risk atypical meningiomas. The presence of a cystic component in these tumors is associated with a high risk of tumor recurrence. A prospective study including a higher number of patients can validate these initial results and respectively lead to risk stratification in the clinical setting.
Acknowledgments
D.K. and A.K. have contributed equally to this work. A part of this work has been presented as a poster at the meeting of the European Association of Neurosurgical Societies (EANS) in Brussels, Belgium, on 26 September 2019, and as an oral presentation at the meeting of German Society of Neurosurgery (DGNC) in Würzburg, Germany, on 15 May 2019.
Supplementary Materials
The following are available online at https://www.mdpi.com/2072-6694/12/10/2942/s1, Table S1: Description of radiomic and semantic features used in tumor analysis.
Author Contributions
Conceptualization D.K., N.K. and A.K.; Methodology D.K., A.K. and N.K.; Software, A.K.; Validation, A.K.; Formal Analysis, D.K.; Investigation, D.K., E.K., N.K., P.L., C.J.S. and H.K.; Writing—Original Draft Preparation, D.K.; Writing—Review and Editing, N.K., M.R. and H.K.; Visualization, D.K.; Supervision, F.R., M.A.B. and C.J.S. All authors read and approved the final manuscript.
Funding
This research was not supported by any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Conflicts of Interest
The authors declare no competing interest.
References
- 1.Louis D.N., Perry A., Reifenberger G., von Deimling A., Figarella-Branger D., Cavenee W.K., Ohgaki H., Wiestler O.D., Kleihues P., Ellison D.W. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary. Acta Neuropathol. 2016;131:803–820. doi: 10.1007/s00401-016-1545-1. [DOI] [PubMed] [Google Scholar]
- 2.Rogers L., Gilbert M., Vogelbaum M.A. Intracranial meningiomas of atypical (WHO grade II) histology. J. Neuro-Oncol. 2010;99:393–405. doi: 10.1007/s11060-010-0343-1. [DOI] [PubMed] [Google Scholar]
- 3.Cao X., Hao S., Wu Z., Wang L., Jia G., Zhang L., Zhang J. Treatment response and prognosis after recurrence of atypical meningiomas. World Neurosurg. 2015;84:1014–1019. doi: 10.1016/j.wneu.2015.05.032. [DOI] [PubMed] [Google Scholar]
- 4.Keric N., Kalasauskas D., Freyschlag C.F., Gempt J., Misch M., Poplawski A., Lange N., Ayyad A., Thomé C., Vajkoczy P. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas. J. Neuro-Oncol. 2020;146:347–355. doi: 10.1007/s11060-019-03382-x. [DOI] [PubMed] [Google Scholar]
- 5.Shakir S.I., Souhami L., Petrecca K., Mansure J.J., Singh K., Panet-Raymond V., Shenouda G., Al-Odaini A.A., Abdulkarim B., Guiot M.-C. Prognostic factors for progression in atypical meningioma. J. Neurosurg. 2018;129:1240–1248. doi: 10.3171/2017.6.JNS17120. [DOI] [PubMed] [Google Scholar]
- 6.Masalha W., Heiland D.H., Franco P., Delev D., Haaker J.G., Schnell O., Scheiwe C., Grauvogel J. Atypical meningioma: Progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy. J. Neuro-Oncol. 2018;136:147–154. doi: 10.1007/s11060-017-2634-2. [DOI] [PubMed] [Google Scholar]
- 7.Schmidt M., Mock A., Jungk C., Sahm F., Ull A.T., Warta R., Lamszus K., Gousias K., Ketter R., Roesch S. Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade. Oncotarget. 2016;7:14551. doi: 10.18632/oncotarget.7396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Sahm F., Schrimpf D., Olar A., Koelsche C., Reuss D., Bissel J., Kratz A., Capper D., Schefzyk S., Hielscher T. TERT promoter mutations and risk of recurrence in meningioma. J. Natl. Cancer Inst. 2016;108:djv377. doi: 10.1093/jnci/djv377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lee G., Lee H.Y., Park H., Schiebler M.L., van Beek E.J., Ohno Y., Seo J.B., Leung A. Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: State of the art. Eur. J. Radiol. 2017;86:297–307. doi: 10.1016/j.ejrad.2016.09.005. [DOI] [PubMed] [Google Scholar]
- 10.Yu H., Scalera J., Khalid M., Touret A.-S., Bloch N., Li B., Qureshi M.M., Soto J.A., Anderson S.W. Texture analysis as a radiomic marker for differentiating renal tumors. Abdom. Radiol. 2017;42:2470–2478. doi: 10.1007/s00261-017-1144-1. [DOI] [PubMed] [Google Scholar]
- 11.Kickingereder P., Burth S., Wick A., Götz M., Eidel O., Schlemmer H.-P., Maier-Hein K.H., Wick W., Bendszus M., Radbruch A. Radiomic profiling of glioblastoma: Identifying an imaging predictor of patient survival with improved performance over established clinical and radiologic risk models. Radiology. 2016;280:880–889. doi: 10.1148/radiol.2016160845. [DOI] [PubMed] [Google Scholar]
- 12.Coroller T.P., Bi W.L., Huynh E., Abedalthagafi M., Aizer A.A., Greenwald N.F., Parmar C., Narayan V., Wu W.W., de Moura S.M. Radiographic prediction of meningioma grade by semantic and radiomic features. PLoS ONE. 2017;12:e0187908. doi: 10.1371/journal.pone.0187908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Morin O., Chen W.C., Nassiri F., Susko M., Magill S.T., Vasudevan H.N., Wu A., Vallières M., Gennatas E.D., Valdes G. Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival. Neuro-Oncol. Adv. 2019;1:vdz011. doi: 10.1093/noajnl/vdz011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Laukamp K.R., Shakirin G., Baeßler B., Thiele F., Zopfs D., Hokamp N.G., Timmer M., Kabbasch C., Perkuhn M., Borggrefe J. Accuracy of radiomics-based feature analysis on multiparametric MR images for non-invasive meningioma grading. World Neurosurg. 2019;132:e366–e390. doi: 10.1016/j.wneu.2019.08.148. [DOI] [PubMed] [Google Scholar]
- 15.Park Y.W., Oh J., You S.C., Han K., Ahn S.S., Choi Y.S., Chang J.H., Kim S.H., Lee S.-K. Radiomics and machine learning may accurately predict the grade and histological subtype in meningiomas using conventional and diffusion tensor imaging. Eur. Radiol. 2019;29:4068–4076. doi: 10.1007/s00330-018-5830-3. [DOI] [PubMed] [Google Scholar]
- 16.Niu L., Zhou X., Duan C., Zhao J., Sui Q., Liu X., Zhang X. Differentiation Researches on the Meningioma Subtypes by Radiomics from Contrast-Enhanced Magnetic Resonance Imaging: A Preliminary Study. World Neurosurg. 2019;126:e646–e652. doi: 10.1016/j.wneu.2019.02.109. [DOI] [PubMed] [Google Scholar]
- 17.Nanda A., Bir S.C., Konar S., Maiti T., Kalakoti P., Jacobsohn J.A., Guthikonda B. Outcome of resection of WHO Grade II meningioma and correlation of pathological and radiological predictive factors for recurrence. J. Clin. Neurosci. 2016;31:112–121. doi: 10.1016/j.jocn.2016.02.021. [DOI] [PubMed] [Google Scholar]
- 18.Stafford S.L., Perry A., Suman V.J., Meyer F.B., Scheithauer B.W., Lohse C.M., Shaw E.G. Primarily resected meningiomas: Outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin. Proc. 1988;73:936–942. doi: 10.4065/73.10.936. [DOI] [PubMed] [Google Scholar]
- 19.Aghi M.K., Carter B.S., Cosgrove G.R., Ojemann R.G., Amin-Hanjani S., Martuza R.L., Curry W.T., Jr., Barker F.G. Long Term Recurrence Rates of Atypical Meningiomas After Gross Total Resection With or Without Postoperative Adjuvant Radiation. Neurosurgery. 2009;64:56–60. doi: 10.1227/01.NEU.0000330399.55586.63. [DOI] [PubMed] [Google Scholar]
- 20.Mair R., Morris K., Scott I., Carroll T.A. Radiotherapy for atypical meningiomas: Clinical article. J. Neurosurg. 2011;115:811–819. doi: 10.3171/2011.5.JNS11112. [DOI] [PubMed] [Google Scholar]
- 21.Komotar R.J., Iorgulescu J.B., Raper D.M., Holland E.C., Beal K., Bilsky M.H., Brennan C.W., Tabar V., Sherman J.H., Yamada Y. The role of radiotherapy following gross-total resection of atypical meningiomas: Clinical article. J. Neurosurg. 2012;117:679–686. doi: 10.3171/2012.7.JNS112113. [DOI] [PubMed] [Google Scholar]
- 22.Jenkinson M.D., Waqar M., Farah J.O., Farrell M., Barbagallo G.M., McManus R., Looby S., Hussey D., Fitzpatrick D., Certo F. Early adjuvant radiotherapy in the treatment of atypical meningioma. J. Clin. Neurosci. 2016;28:87–92. doi: 10.1016/j.jocn.2015.09.021. [DOI] [PubMed] [Google Scholar]
- 23.Alvarez F., Roda J.M., Romero M.P., Morales C., Sarmiento M.A., Blázquez M.G. Malignant and atypical meningiomas: A reappraisal of clinical, histological, and computed tomographic features. Neurosurgery. 1987;20:688–694. doi: 10.1227/00006123-198705000-00003. [DOI] [PubMed] [Google Scholar]
- 24.Hwang W.L., Marciscano A.E., Niemierko A., Kim D.W., Stemmer-Rachamimov A.O., Curry W.T., Barker F.G., Martuza R.L., Loeffler J.S., Oh K.S. Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. Neuro-Oncol. 2016;18:863–872. doi: 10.1093/neuonc/nov285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hsu C.-C., Pai C.-Y., Kao H.-W., Hsueh C.-J., Hsu W.-L., Lo C.-P. Do aggressive imaging features correlate with advanced histopathological grade in meningiomas? J. Clin. Neurosci. 2010;17:584–587. doi: 10.1016/j.jocn.2009.09.018. [DOI] [PubMed] [Google Scholar]
- 26.Spille D.C., Sporns P.B., Heß K., Stummer W., Brokinkel B. Prediction of high-grade histology and recurrence in meningiomas using routine preoperative magnetic resonance imaging—A systematic review. World Neurosurg. 2019;128:174–181. doi: 10.1016/j.wneu.2019.05.017. [DOI] [PubMed] [Google Scholar]
- 27.Katz L.M., Hielscher T., Liechty B., Silverman J., Zagzag D., Sen R., Wu P., Golfinos J.G., Reuss D., Neidert M.C. Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol. 2018;135:955–963. doi: 10.1007/s00401-018-1844-9. [DOI] [PubMed] [Google Scholar]
- 28.Surov A., Hamerla G., Meyer H.J., Winter K., Schob S., Fiedler E. Whole lesion histogram analysis of meningiomas derived from ADC values. Correlation with several cellularity parameters, proliferation index KI 67, nucleic content, and membrane permeability. Magn. Reson. Imaging. 2018;51:158–162. doi: 10.1016/j.mri.2018.05.009. [DOI] [PubMed] [Google Scholar]
- 29.Hale A.T., Stonko D.P., Wang L., Strother M.K., Chambless L.B. Machine learning analyses can differentiate meningioma grade by features on magnetic resonance imaging. Neurosurg. Focus. 2018;45:E4. doi: 10.3171/2018.8.FOCUS18191. [DOI] [PubMed] [Google Scholar]
- 30.Kikinis R., Pieper S.D., Vosburgh K.G. Intraoperative Imaging and Image-Guided Therapy. Springer; Berlin/Heidelberg, Germany: 2014. 3D Slicer: A platform for subject-specific image analysis, visualization, and clinical support; pp. 277–289. [Google Scholar]
- 31.Jolesz F.A. Intraoperative Imaging and Image-Guided Therapy. Springer Science & Business Media; Berlin/Heidelberg, Germany: 2014. [Google Scholar]
- 32.Vallières M., Freeman C.R., Skamene S.R., El Naqa I. A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. Phys. Med. Biol. 2015;60:5471. doi: 10.1088/0031-9155/60/14/5471. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.